Poly Medicure Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Poly Medicure Ltd. on BSE

Load latest

Poly Medicure Ltd.

14 Feb 2024

2002.00

0.95%

Company Update

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

In continuation od earlier intimation given on 31st January, 2024, pursuant to the provisions of Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 10(c) of SEBI(Share Based Employee Benefits and Sweat Equity) Regulations, 2021, as amended, please note that the Nomination and Remuneration Committee of the Board of Directors on 31st January, 2024 allotted 26,375 equity shares of face value of Rs. 5/- each exercised under Employee Stock Option Plan 2020(ESOS 2020).

pdf

Poly Medicure Ltd.

09 Feb 2024

2002.00

0.95%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submit Transcript of the Investor Meet/Call held on 02nd February, 2024 at 04:00 P.M(IST) on the Unaudited Financial Results of the Company for the quarter ended 31st December, 2023 on Standalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 31st January, 2024.

pdf

Poly Medicure Ltd.

03 Feb 2024

2002.00

0.95%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Friday, February 02, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended December 31, 2023 , is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/02/ICI3420240202151273.mp3

pdf

Poly Medicure Ltd.

03 Feb 2024

2002.00

0.95%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, 2nd February, 2024 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 31st December, 2023. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.

pdf

Poly Medicure Ltd.

31 Jan 2024

2002.00

0.95%

Result

POLY MEDICURE LTD. - 531768 - Quarterly Statndalone & Consolidated Financial Results In Compliance Of Regulation …

BSE India

Quarterly Standalone and Consolidated Financial Results for the quarter ended 31st December, 2023.

pdf

Poly Medicure Ltd.

31 Jan 2024

2002.00

0.95%

Board Meeting

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2024, at registered office at 232-B, 3rd floor, Okhla industrial estate, PHASE-III, New Delhi -110020, approved the following businesses: a. On recommendation of Nomination Remuneration Committee approve the reappointment of Shri Dhruv Baid as Senior Manager, International Business Development for Five years with effect from 1st April 2024. b. Nomination & Remuneration Committee, has allotted 26,375 shares having face value of Rs 5/- each to its eligible employees of the Company who has exercise the option Under its Employee Stock Option Scheme, 2020. c. Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and Nine months ended on 31st December 2023. d. Adoption of New set of Article of Association of the Company. e. Any Other Item.

pdf

Poly Medicure Ltd.

29 Jan 2024

2002.00

0.95%

Company Update

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

pdf

Poly Medicure Ltd.

19 Jan 2024

2002.00

0.95%

Board Meeting

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting …

BSE India

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday, the 31st day of January, 2024 inter-alia to consider the following: To consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter and Nine Months ended on 31st December, 2023 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. To transact any other matter which the Board may deem fit.

pdf

Poly Medicure Ltd.

12 Jan 2024

2002.00

0.95%

Company Update

POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In terms Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificate received from M/s Mas Services Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2023.

pdf

Poly Medicure Ltd.

30 Dec 2023

2002.00

0.95%

SAST

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

BSE India

It may be noted that Trading window of the Companyhas been kept closed for designated persons from Monday, the 01st JANUARY, 2024 till the end of 48 hours after the declaration of financial Results for the quarter ended 31st Decemeber, 2023.

pdf

Is Poly Medicure Ltd. worth buying?

187 Votes:

Buy 81.82%

Sell 12.3%

Hold 5.88%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf